AllyGPO® and BioCareSD®, mission-aligned partners dedicated to transforming specialty drug group purchasing and distribution, today announced their strategic partnership has earned a Gold Globee in the 6th Annual 2026 Globee Awards for Pioneers. The partnership was...
AllyGPO®, a leading innovator and next-generation specialty group purchasing organization (GPO), and BioCareSD®, a national specialty distributor with nearly 50 years of experience delivering high-touch specialty drug distribution services, today announced that Utah Cancer Specialists, one...
BioCareSD, a BioCare company and national specialty pharmaceutical distributor, today announced a new partnership with WeInfuse, a leading infusion management technology platform used by providers across more than 1,300 locations nationwide. The collaboration will enable closer...
A leading innovator and next-generation specialty group purchasing organization (GPO), and BioCareSD®, a national specialty drug distributor with nearly 50 years of experience delivering life‑saving therapies through high‑touch service and a differentiated distribution model, today announced...
LogiCare3PL today announced it has been selected by Harrow, Inc. (Nasdaq: HROW) as a distribution partner for Harrow's portfolio of ophthalmic disease management solutions. Effective February 1, 2026, LogiCare3PL is providing both non-title and 3PL title...
LogiCare3PL, a division of BioCare, Inc., is pleased to announce a strategic partnership with ChiRhoClin, Inc., a leader in pancreatic and gastrointestinal diagnostics. Effective July 14, 2025, LogiCare3PL will serve as the exclusive third-party logistics provider...
Oklahoma Cancer Specialists and Research Institute (OCSRI), a leading independent community oncology practice, has officially selected BioCareSD and AllyGPO as its primary specialty drug distributor and group purchasing organization (GPO). This strategic partnership marks a milestone for both organizations and underscores...
LogiCare3PL is proud to support the commercial launch of VYKAT™ XR, Soleno Therapeutics' newly FDA-approved therapy and the first and only treatment indicated for hyperphagia in patients with Prader-Willi syndrome (PWS). This milestone marks a significant advancement...
BioCare, a leader in specialty pharmaceutical distribution, is excited to announce its new partnership with AeroSafe Global, a pioneer in reliable, sustainable cold chain solutions. This collaboration introduces an innovative, reusable temperature-controlled shipping solution designed to...
BioCareSD, a leading specialty distributor for orphan, rare, and ultra-rare diseases, is excited to announce its new limited distribution partnership with GCBioPharma for ALYGLO® (immune globulin intravenous, human-stwk). ALYGLO® is a 10% immune globulin liquid for...
